Somatic Mutation Analysis of the SDHB, SDHC, SDHD, and RET Genes in the Clinical Assessment of Sporadic and Hereditary Pheochromocytoma

Hormones and Cancer

Volumn 3, Issue 4, 2012, Pages 187-192

  Weber, Alexander ^a   Hoffmann, Michael M ^a   Neumann, Hartmut P H ^a   Erlic, Zoran ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PARAGANGLIOMA SYNDROMES TYPE 1; PARAGANGLIOMA SYNDROMES TYPE 3; PARAGANGLIOMA SYNDROMES TYPE 4; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ADULT; AGE; AGED; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENDER; GENE INACTIVATION; HEREDITARY PHEOCHROMOCYTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2; MUTATION RATE; MUTATIONAL ANALYSIS; ONCOGENE; PHEOCHROMOCYTOMA; POINT MUTATION; PRIORITY JOURNAL; SOMATIC MUTATION; SPORADIC PHEOCHROMOCYTOMA; TUMOR VOLUME;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; FEMALE; GERM-LINE MUTATION; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHEOCHROMOCYTOMA; PROTO-ONCOGENE PROTEINS C-RET; SEQUENCE ANALYSIS, DNA; SUCCINATE DEHYDROGENASE; YOUNG ADULT;

EID: 84863208321     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-012-0113-y     Document Type: Article

References (27)

1. Neumann HP, Eng C (2009) The approach to the patient with paraganglioma. J Clin Endocrinol Metab 94(8): 2677-2683.
2. Erlic Z, Neumann HP (2009) Familial pheochromocytoma. Hormones (Athens) 8(1): 29-38.
3. Qin Y, Yao L, King EE et al (2010) Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet 42(3): 229-233.
4. Yao L, Schiavi F, Cascon A et al (2010) Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas. JAMA 304(23): 2611-2619.
5. Neumann HP, Sullivan M, Winter A et al (2011) Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites. J Clin Endocrinol Metab 96(8): E1279-E1282.
6. Comino-Méndez I, Gracia-Aznárez FJ, Schiavi F et al (2011) Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet 43(7): 663-667.
7. Burnichon N, Brière JJ, Libé R et al (2010) SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 19(15): 3011-3020.
8. Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68(4): 820-823.
9. Eng C, Crossey PA, Mulligan LM et al (1995) Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas. J Med Genet 32(12): 934-937.
10. Bender BU, Gutsche M, Gläsker S et al (2000) Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas. J Clin Endocrinol Metab 85(12): 4568-4574.
11. Kytölä S, Nord B, Elder EE et al (2002) Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas. Gene Chromosome Canc 34(3): 325-332.
12. Dannenberg H, van Nederveen FH, Abbou M et al (2005) Clinical characteristics of pheochromocytoma patients with germline mutations in SDHD. J Clin Oncol 23(9): 1894-1901.
13. Korpershoek E, Petri BJ, van Nederveen FH et al (2007) Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma. Endocr Relat Cancer 14(2): 453-462.
14. Gimenez-Roqueplo AP, Favier J, Rustin P et al (2002) Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. J Clin Endocrinol Metab 87(10): 4771-4774.
15. Cascon A, Ruiz-Llorente S, Fraga MF et al (2004) Genetic and epigenetic profile of sporadic pheochromocytomas. J Med Genet 41(3): e30.
16. Gimenez-Roqueplo AP, Favier J, Rustin P et al (2003) Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res 63(17): 5615-5621.
17. Astuti D, Morris M, Krona C et al (2004) Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma. Br J Cancer 91(10): 1835-1841.
18. Sun HY, Cui B, Su DW et al (2006) LOH on chromosome 11q, but not SDHD and Men1 mutations was frequently detectable in Chinese patients with pheochromocytoma and paraganglioma. Endocrine 30(3): 307-312.
19. van Nederveen FH, Korpershoek E, Lenders JW et al (2007) Somatic SDHB mutation in an extraadrenal pheochromocytoma. N Engl J Med 357(3): 306-308.
20. Benn DE, Croxson MS, Tucker K et al (2003) Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas. Oncogen 22(9): 1358-1364.
21. Gimm O, Armanios M, Dziema H et al (2000) Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. Cancer Res 60(24): 6822-6825.
22. Erlic Z, Rybicki L, Peczkowska M et al (2009) Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients. Clin Cancer Res 15(20): 6378-6385.
23. Pigny P, Vincent A, Cardot Bauters C et al (2008) Paraganglioma after maternal transmission of a succinate dehydrogenase gene mutation. J Clin Endocrinol Metab 93(5): 1609-1615.
24. Neumann HP, Erlic Z (2008) Maternal transmission of symptomatic disease with SDHD mutation: fact or fiction? J Clin Endocrinol Metab 93(5): 1573-1575.
25. Braun S, Riemann K, Kupka S et al (2005) Active succinate dehydrogenase (SDH) and lack of SDHD mutations in sporadic paragangliomas. Anticancer Res 25(4): 2809-2814.
26. López-Jiménez E, Gómez-López G, Leandro-García LJ et al (2010) Research resource: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas. Mol Endocrinol 24(12): 2382-2391.
27. Koch CA, Huang SC, Zhuang Z et al (2002) Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma. Oncogene 21(3): 479-482.